Featured Speakers:
Barry R. Goldspiel, PharmD BCPS BCOP
Deputy Chief
National Institutes of Health Clinical Center
Pharmacy Department
Bethesda, MD
Sapna R. Amin, PharmD BCOP
Manager, Investigational Pharmacy Services
Division of Pharmacy
MD Anderson Cancer Center
Houston, TX
Joyce S. Lee, PharmD BCOP BCPS
Clinical Pharmacist, IDS/Oncology
Department of Pharmacy
Assistant Professor, Division of Hematology/Oncology
University of California–Davis Medical Center
Sacramento, CA
Description:
Learn how the HOPA Investigational Drug Service Best Practice
Standards addresses the pharmacist's crucial role in investigational
studies across the life cycle of a protocol, the investigational drug
service's roles and responsibilities, and special circumstances related
to medication therapy access on protocols.
Learning Objectives:
- Describe the crucial role of Pharmacy, Pharmacists, and Pharmacy Technicians in Investigational Drug Services (IDS)
- Provide best practice recommendations to pharmacists for investigational drug management
- Provide information about expanded access to investigational medications
Credits: 1.0 contact hours (.10 CEU)
Registration Fees:
Individual
HOPA Member Free
Nonmember $65